Mr. Justin Hanka reports
MINDBIO LAUNCHES INTOX AI IN MAJOR ADVANCEMENT FOR DRUG USE DETECTION
Mindbio Therapeutics Corp. has launched its lead commercial software Intox AI for validation and testing.
Mindbio's enterprise solution for intoxication and fatigue detection, Intox AI, enables new analytical capabilities to detect cocaine, cannabis, alcohol, psychedelics, narcotic use and human fatigue from voice. Intox AI is a category changer in drug use and fatigue detection in high-risk industries where sobriety and alertness are an essential health and safety requirement that saves lives. The technology will be deployed to the Edge AI kiosks that are due for initial prototype manufacturing completion shortly. The company is targeting industries for commercialization that have pressure to scale up drug and alcohol testing and where testing is mandated by regulators, such as the mining industry, aviation and construction, heavy transport, and law enforcement, and where high-volume testing at scale for a variety of drugs, alcohol and human fatigue presents major challenges for management.
The current systems for drug and alcohol testing involve a mouth swab test and breathalyzer. These tests are time-consuming, costly on a per-test basis, and unhygienic and environmentally harmful due to the quantity of plastic use and waste disposal. Mindbio's voice AI solution aims to provide quick scanning for intoxication and removes these problems from legacy drug testing procedures. Mindbio's solution aims to deliver enhanced efficiency and testing at scale, not possible with current systems.
The company's chief executive officer Justin Hanka said: "The launch of Intox AI is a significant advancement for drug and alcohol testing across a range of substances that affect human performance and safety. The company is on track to deliver its first prototype testing kiosks shortly and is delighted the core software is ready for testing and validation."
About Mindbio Therapeutics Corp.
Mindbio is a biotechnology company that is commercializing artificial intelligence prediction technologies for drug and alcohol intoxication detection through voice analysis across a range of substances. The AI prediction model uses millions of data points analyzed in real time and in seconds to predict intoxication and fatigue with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
An anonymous director reports
© 2026 Canjex Publishing Ltd. All rights reserved.